Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

AIDS - Tập 15 Số 1 - Trang 71-75 - 2001
Catia Marzolini1, Amalio Telenti1, Laurent A. Décosterd1, Gilbert Greub1, Jérôme Biollaz1, Thierry Buclin1,2,3,4
1Sponsorship: This work was supported by a grant from the Swiss National Science Foundation (no. 3344-062092.00).
2Thierry Buclin, Division of Clinical Pharmacology, Beaumont 06-633, Department of Medicine, University Hospital (CHUV), 1011 Lausanne, Switzerland. Tel: +41 21 314 42 65
3e-mail: [email protected]
4fax: +41 21 314 42 66

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adkins, 1998, Drugs, 56, 1055, 10.2165/00003495-199856060-00014

Joly, 1999, AIDS Rev, 1, 37

Katlama, 1999, Int J Clin Pract, Suppl 103, 16

Gazzard, 2000, HIV Med, 1, 11, 10.1046/j.1468-1293.2000.00009.x

Staszewski, 1999, N Engl J Med, 341, 1865, 10.1056/NEJM199912163412501

Gazzard, 1999, Int J Clin Pract, 53, 60, 10.1111/j.1742-1241.1999.tb11662.x

Moyle, 1999, Int J Clin Pract, Suppl 103, 29

Fletcher, 1999, Ann Pharmacother, 33, 989, 10.1345/aph.19075

Durant, 2000, AIDS, 14, 1333, 10.1097/00002030-200007070-00005

Marzolini, 2000, J Chromatogr B, 740, 43, 10.1016/S0378-4347(99)00573-3

Villani, 1999, Br J Clin Pharmacol, 48, 712, 10.1046/j.1365-2125.1999.00071.x

Thông tin
Thông tin xuất bản

AIDS

Tập 15 Số 1

71-75

Thông tin tác giả